Evaluation of Preoperative Chemotherapy with Modified OPTIMOX-1 Plus Bevacizumab in Patients with Advanced Rectal Cancer with Factors Contraindicative of Curative Surgery.

Chihiro KosugiKeiji KodaKuniya TanakaMasato SuzukiMasato YamazakiKiyohiko ShutoKenichi MatsuoAtsushi HiranoHidehito ArimitsuRisa ShiragamiHideki Yasuda

Published in: Hepato-gastroenterology (2016)

These findings suggest the potential utility of neoadjuvant chemotherapy consisting of modified OPTIMOX1 plus bevacizumab prior to permitting radical resection or anus-preserving surgery in patients with highly advanced rectal cancer.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
minimally invasive
coronary artery bypass
sentinel lymph node
squamous cell carcinoma
radiation therapy
metastatic colorectal cancer
surgical site infection
patients undergoing
coronary artery disease
lymph node
atrial fibrillation